GenEng News  Apr 25  Comment 
Shire’s board last night set the stage for a potential Takeda acquisition by saying it would recommend to shareholders approval of Takeda’s approximately £46 billion ($64 billion) offer for the company—if other terms can be worked out. ...
The Economic Times  Apr 25  Comment 
The Nikkei ended 0.3 per cent lower to 22,215.32.
Channel News Asia  Apr 24  Comment 
London-listed drugmaker Shire Plc and Japan's Takeda Pharmaceutical Co Ltd plan to announce a preliminary deal on Wednesday, after the latter sweetened its US$62 billion acquisition offer, people familiar with the matter said.
Financial Times  Apr 24  Comment 
The very special relationship between the presidents of the US and France
Wall Street Journal  Apr 24  Comment 
Takeda made a fifth takeover proposal for rival drugmaker Shire, a last-ditch move by the Japanese company that would likely value the rare-drug specialist at more than $60 billion.
FierceBiotech  Apr 24  Comment 
Takeda, with apparently near infinitely deep pockets for M&A and collaborations, has struck a deal: not to buy Shire, as yet, but rather with Nektar, as the two eye new trials of their respective immuno-oncology assets.


No more s***. All posts of this qaultiy from now on

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki